One sentence summary: Down-modulation of the apoptotic pathway leads to a persistent replication of human metapneumovirus in human lung epithelial cells. Editor: Alfredo Garzino-Demo
INTRODUCTION
Epidemiological, clinical and pathological data suggest a strong correlation in children between severe viral infections of the respiratory tract in early life and increased risk of developing asthma and chronic obstructive pulmonary disease later in life (Martin, Siddiqui and Hassan 2006; Tregoning and Schwarze 2010) . Indeed, clinical resolution of viral infection does not always coincide with virus clearance from the host and longterm viral action may cause an aberrant local immune response and lung tissue damage (Holtzman et al. 2005; Mohapatra and Boyapalle 2008) . This is the case, for example, for respiratory syncytial virus (RSV), which causes acute and chronic manifestations of asthma, as well as chronic bronchitis (Holtzman et al. 2005) , because of its ability to persist in the host's respiratory tract. Inability to completely eliminate the virus depends generally on a number of host and viral factors (Holtzman et al. 2005; Ng et al. 2013) , which still remain largely unknown.
Human metapneumovirus (hMPV), classified within the Paramyxoviridae family, has been identified as a worldwide agent causing acute respiratory diseases and serious clinical manifestations in pediatric subjects (Caracciolo et al. 2008; Anderson et al. 2012; Apostoli et al. 2012) . Following hMPV inhalation and replication in the upper respiratory tract, viral particles can reach the bronchial area and cause severe bronchitis and bronchiolitis. Approximately 5-15% of all respiratory tract infections of infants and toddlers are caused by hMPV, making it the second most common cause of hospitalization of young children after RSV (Boivin et al. 2003) .
hMPV infection is associated with an increased risk of developing chronic obstructive pulmonary disease and exacerbating asthma (Martinello et al. 2006; Falsey et al. 2008) . Garcia-Garcia et al. (2007) showed that hMPV infection during infancy may be a significant risk factor for development of preschool asthma, thus highlighting not only an association of viral infection with acute exacerbation in asthmatic children but also the possibility for hMPV to initiate development of asthma in the first 5 years of life. Despite this clinical evidence, little or nothing is known on a possible chronic persistence of the virus in the human host. On the other hand, hMPV persistence has been studied in depth using permissive small animal models. Murine experimental models of hMPV infection have shown a prolonged low-rate virus replication in the respiratory tract and provided evidence for a virus-triggered chronic inflammatory state. Furthermore, replicating virus was retrieved up to 60 days postinfection (dpi) despite the presence of neutralizing antibodies, suggesting that hMPV circumvents host immune responses and causes long-term lung damage (Alvarez et al. 2004; Liu et al. 2009 ). Another group reported asthma-like signs of disease, including airway obstruction, following hMPV challenge in mice (Kolli et al. 2008) . Hamelin et al. (2006) also observed chronic inflammation in the lung of hMPV-infected mice for up to 154 dpi, with viral RNA detected for the whole duration of the chronic pathology seen in the lungs. So far, hMPV persistence has been shown in neuronal cell processes in the lung by in situ hybridization. This immune privileged area could harbor the virus for extended periods of time and sustain virus reactivation following glucocorticoid treatment (Liu et al. 2009 ).
Even if murine biology cannot be assumed to accurately represent the entire complexity of the human response (Gentile et al. 2014) , all the results obtained in these small animal models point to a possible direct role of hMPV in airway hyperresponsiveness and inflammation and to its ability to persist in the lung. At the same time, it is clearly evident that so far no in vitro or in vivo studies have supported hMPV persistence in human cells.
Apoptosis or programmed cell death is a common cell response to acute viral infection (Hay and Kannourakis 2002; Hilleman 2004 ) that limits replication and spreading and ultimately favors virus clearance. Whereas an acutely infective virus needs to prevent apoptosis of infected cells only long enough to produce progeny virions, a persistent virus must have a means to suppress apoptosis for a much longer time in order to maintain a compartment of infected cells. When cells are induced to overcome the apoptotic process, a coexistence of virus and its target cells may occur and persistent infection can be established (Chattopadhyay et al. 2013) .
In this study we sought to investigate whether human alveolar epithelial cells, which are the first cells to come into contact with hMPV and represent its primary target of infection, can survive the acute infection and allow viral persistence by modifying the intracellular pathways of programmed cell death.
MATERIALS AND METHODS

Cell cultures
Rhesus monkey kidney epithelial LLC-MK2 and human lung adenocarcinoma epithelial A549 cells were obtained from the American Type Culture Collection and cultured in minimum essential medium supplemented with Glutamax TM , 10% fetal calf serum and 2 mM sodium pyruvate (Thermo Fisher Scientific).
hMPV propagation and titration
The propagation of strain NL-001 of hMPV (GenBank accession number: AF371337) (a kind gift from Dr Osterhaus, Departments of Virology and Pediatrics, Erasmus University Medical Center, Rotterdam, The Netherlands) was carried out in LLC-MK2 cells as described previously (Dinwiddie and Harrod 2008) . Briefly, subconfluent LLC-MK2 cells cultured for 48-72 h in OPTIMEM (Thermo Fisher Scientific) were infected at multiplicity of infection (MOI) 0.5 for 3 h at 37
• C. After virus adsorption, OP-TIMEM was added and the cells were incubated at 37
• C until an evident cytopathic effect was observed. hMPV was then recovered from supernatants and cell lysates. To remove cell debris, hMPV stocks were clarified by centrifugation at 4000 g for 30 min at 4 • C and stored at −80 • C until use. Virus titer was obtained by limiting dilution assay. Briefly, LLC-MK2 cells were seeded in 96-well plates and infected using a 4-fold diluted virus. Titer was obtained by real-time RT-PCR evaluating the disappearance of viral progeny in cell supernatants and confirmed by immunocytochemistry. For all the experiments A549 cells (at 80% confluence) were infected with hMPV at MOI 0.25. After 3 h of adsorption, complete medium was added to allow cell recovery, and after 24 h, medium was completely replaced. Uninfected cells shown in the experiments have been subjected to the same culture protocol.
Flow cytometry analysis
Infection of cells was assessed by detecting the expression of the hMPV protein F on the cell surface. Cells were washed with phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde for 30 min at 4
• C and then stained for 30 min on ice with a mAb to protein F (Mab80124) or with an unrelated mAb (Millipore). After washing with cold PBS, cells were incubated for 30 min with an anti-mouse antibody conjugated to Alexa Fluor 647 (Invitrogen). The cell cycle was analyzed by flow cytometry. In brief, infected or uninfected cells were harvested by trypsinization, washed with PBS and pelleted by centrifugation. Then, cells were fixed in 95% ethanol at 4
• C for at least 30 min and stained for nuclear DNA content with 50 μg/ml propidium iodide (SigmaAldrich) and 1 mg/ml RNase A at room temperature for 30 min (Sigma-Aldrich). All experiments were performed with a FACSCalibur flow cytometer and data were acquired and analyzed by using CellQuest Software (BD Biosciences). Quantification of the number of copies of viral RNA was performed by the interpolation of data using a standard curve. To this end the plasmid pGEM T Vector containing a part of the hMPV gene sequence (nt 570-1076) was generated. The standard curve was obtained by serial dilutions of the plasmid.
RNA purification and real-time PCR
Terminal deoxynucleotidyl transferase dUTP nick end labeling assay
Detection of apoptotic DNA fragmentation was performed using the APO-BrdUTM TUNEL Assay Kit (Invitrogen) according to the manufacturer's instructions. Cells (3 × 10 5 ) were placed on 10 mm slides using cytospin at 1500 rpm for 5 min, fixed with 4% paraformaldehyde for 20 min on ice, then permeabilized with 0.2% Triton X-100 in PBS for 5 min, washed with PBS and stored at 4 • C. Then, cells were incubated for 1 h at 37
• C with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) reaction mixture containing the terminal deoxynucleotidyl transferase and for additional 30 min at room temperature with the antibody anti-BrdU conjugated to Alexa Fluor 488. Twenty-five microliters of 4 , 6-diamidino-2-phenylindole (DAPI) was added on each slide and the cells were incubated for 30 min at room temperature, protected by light, and finally analyzed with a fluorescence microscope (Olympus BX 51). As positive control, cells were incubated, before the addition of the TUNEL reaction mixture, for 10 min at room temperature with DNase I solution included in the TUNEL assay.
Measurement of caspase activity
Caspase activity was evaluated by using the Caspase-Glo R 3/7 Assay Kit (Promega), which measures the combined activity of caspases 3 and 7. Infected and uninfected A549 cells were counted and collected at different time points. The same number of cells for each sample was incubated for 1 h in the dark with the Caspase-Glo reagent according to the munufacturer's instructions. The reagent provides a proluminescent caspase-3/7 substrate, which contains the tetrapeptide sequence DEVD, in combination with luciferase and a cell-lysing agent. The addition of the Caspase-Glo 3/7 reagent results in cell lysis, followed by caspase cleavage of the DEVD substrate and generation of luminescence. Luminescence, which is proportional to the amount of caspase activity in the sample, was detected using a luminometer.
Cell viability assay
Cell viability was evaluated according to the manufacturer's instructions with a Cell Titer-Glo Luminiscent Cell Viability Assay (Promega), which is based on the quantification of ATP. The same number of infected and uninfected cells was analyzed.
Western blot analysis
Total protein extracts were obtained from hMPV infected or uninfected A549 cells. Cells were lysed in 50 μl of lysis buffer containing Hepes 10 mM pH 7.9, KCl 10 mM, MgCl 2 1.5 mM, EDTA 0.5 mM, EGTA 0.5 mM, NP40 0.6%, Na 3 VO 4 1 mM, NaF 50 mM, phenylarsine oxide (PAO) 20 μM and a mixture of protease inhibitors (Sigma-Aldrich). After incubation on ice for 20 min, the samples were centrifuged at 14,000 × g for 10 min at 4
• C and the supernatants were collected and stored at −80 • C. The total concentration of proteins was detected by QuantiPro TM BCA Assay (Sigma-Aldrich). Equal amounts of total proteins were resolved on 11% SDS-polyacrylamide gel and then electroblotted onto a polyvinylidene difluoride membrane. The blots were then incubated with antibodies to poly (ADP-ribose) polymerase 1 (PARP-1), p21, p53, B-cell lymphoma 2 (Bcl-2), p-Wee1 (Ser642) and β-actin (Santa Cruz Biotechnology). Antigen-antibody complexes were revealed by incubating the membranes at room temperature with peroxidase-conjugated anti-mouse or anti-rabbit antibodies (Thermo Fisher Scientific), depending on the primary antibody used, revealed using the ECL system (Santa Cruz Biotechnology) with images captured by the ChemiDoc-It Imaging System. The integrated optical density was determined using Gel-Pro Analyzer 6.0 software.
Statistical analysis
Data obtained from multiple independent experiments are expressed as the means ± SD. Data were analyzed for statistical significance using a paired two-tail Student's t-test. Differences were considered significant at P < 0.05. Statistical tests were performed using Prism version 5 software (GraphPad).
RESULTS
Human A549 lung epithelial cells surviving MPV infection are highly metabolically active
In order to monitor the behavior of airway epithelial cells during acute hMPV infection, we used a MOI of 0.25 to infect human lung adenocarcinoma epithelial A549 cells, which represent the most physiological model suitable for studying the acute response (Bao et al. 2007 ). Microscopic analysis of infected cell cultures highlighted an initial 3-day period of massive cell death, with an even more evident lytic effect at 7 and 14 dpi (Fig. 1) . As expected, infection was productive throughout the period of observation, as assessed by quantification of virus RNA in hMPV-infected A549 cells. In fact, supernatants collected at 3, 5, 7 and 14 dpi showed a continuous increase of virus titer over time (Fig. 2a) . In order to assess the viability of hMPV released from infected cells, we titrated the virus in supernatants collected at day 14 post-infection using LLC-MK2 cells and infected fresh A549 cells at MOI 0.25. Evaluation of the virus released over time (3, 5, 7 and 14 dpi) in the supernatant by real-time PCR highlighted increased levels of hMPV during the period of observation (Fig. 2b) . Due to the presence of residual A549 cells in culture at 14 dpi (6 ± 2% of the originally seeded cells), we wondered whether these elements were still alive. Cell viability testing was performed using the Titer-Glo R Luminescent Cell Viability Assay, which is based on determination of intracellular ATP concentration, an indicator of metabolically active cells. As shown in Fig. 2c , the residual cells at day 14 post-infection were metabolically active. The difference in cell density may account for the significantly higher level of ATP content detected in infected as compared with uninfected cells.
To further confirm that surviving A549 cells were hMPVinfected, we evaluated the expression of the hMPV protein F on the cell surface. The data obtained demonstrated that residual cells were for the most part infected, with 78 ± 7% of cells being F-positive (Fig. 2d ). All these data show that despite a massive cell death, residual hMPV-infected cells collected at 14 dpi are metabolically active.
hMPV induces apoptosis in A549 cells through PARP-1 cleavage and caspase-3 and -7 activation
Virus infection and replication are often associated with apoptosis, which is likely to be responsible for much of the various pathologies associated with infectious diseases (Thomson 2001 ). hMPV's ability to induce apoptotic effects in A549 cells was examined by TUNEL assay. As shown in Fig. 3a , numerous apoptotic nuclei and DNA fragmentation was already present at days 3 and 7 post-infection. Induction of apoptosis in A549 cells was also evaluated by assessing PARP-1 cleavage, which is . The PARP-1 cleavage was analyzed by western blot on hMPV-infected cell lysates collected at different times post-infection. As shown in Fig. 3b , cleaved PARP-1 (85 kDa fragment) was highly evident at 3 and 7 dpi, but interestingly it was sharply reduced at day 14 post-infection. Since PARP-1 is only one of several known cellular substrates of caspases (Margolin et al. 1997) , we further analyzed the activity of caspase-3 and caspase-7, which are considered the key effector molecules in the apoptotic process responsible for in vivo PARP-1 cleavage and DNA fragmentation (Slee, Adrain and Martin 2001) . Data obtained show that in hMPV-infected A549 cells, the caspase activity gradually increased up to 7 dpi and then decreased at 14 dpi (Fig. 3c) . Overall, these data confirm the ability of hMPV to induce apoptosis in A549 cells up to 7 dpi and, on the other side, highlight the capability of residual epithelial cells to reverse the apoptotic process at 14 dpi. Western blot analysis shows that the expression of p53 and p21 remained invariant (a), while Wee1 phosphorylation at Ser642 was increased at all times tested (b), as verified by densitometric analysis and plotting of p53/β-actin, p21/β-actin and pWee1/β-actin. In the left panel, one representative blot of three with similar results is shown. In the right panel, values reported are the means ± SD of three independent experiments. Statistical analysis was performed by Student's t-test. * * P < 0.01; * * * P < 0.001. FI, fold increase; I, infected; NI, not infected.
Apoptosis induced by hMPV in A549 cells depends on Wee1 kinase and does not involve the p53/p21 pathway
DNA damage activates the p53/p21 pathway, which plays an important role in modulating the apoptotic response by controlling the G2/M and G1 cell cycle checkpoints (Agarwal et al. 1995 (Agarwal et al. , 1998 Abbas and Dutta 2009 ). Moreover, Groskreutz et al. (2007) showed that RSV infection reduces the level of p53 to increase cell survival and, consequently, promote viral replication. In order to assess if both p53 and p21 could be involved in the hMPV-driven apoptotic process, we evaluated the expression of these proteins in A549 cells. Surprisingly, western blot analysis performed on cell lysates obtained at 3, 7 and 14 dpi showed that neither protein was modulated at any tested time (Fig. 4a) . Then, we evaluated the possible involvement of Wee1, a key regulator of DNA damage-induced apoptosis and cell cycle progression, which negatively regulates cell cycle progression by phosphorylating and deactivating cyclin-associated cyclin-dependent kinases. In particular, we assessed Wee1 phosphorylation in Ser642, which is known to be activated and have increased kinase activity after DNA damage (Wang et al. 2000; Lee, Kumagai and Dunphy 2001; Rothblum-Oviatt, Ryan and Piwnica-Worms 2001) . Western blot analysis, performed on cell lysates of A549 obtained at 3, 7 and 14 dpi, showed that Wee1 phosphorylation increased at all the times tested (Fig. 4b) . Taken together these results suggest that the Wee1 kinase is involved in the hMPV-driven apoptosis of A549 cells, whereas p53 and p21 molecules do not contribute to this event.
hMPV establishes a persistent infection in A549 cells
Studies performed in acute infection models have shown that different viruses are able to interfere with the cell cycle of infected cells by blocking them in G0/G1 or G2/M phase (Davy and Doorbar 2007; Emmett et al. 2005; Zhao and Elder 2005) . In our experiments we found that at 14 dpi, hMPV-infected residual cells were metabolically active and showed a trend toward inhibition of apoptosis. However, hMPV-infected A549 cell recovery from apoptotic events was not associated with a clear rescue in cell proliferation. Based on these observations, we asked whether hMPV could establish a persistent infection characterized by a long-lasting cell growth deregulation. Monitoring hMPV-infected cultures over time showed that growth of viral infected A549 was severely impaired until 28 dpi and that a re-establishment of cell growth became evident at 42 dpi (Fig. 5) . These results were confirmed by cell cycle analysis. As shown in Fig. 6a , hMPVinfected cells at 14 dpi accumulated more in S (23 ± 2%) and G 2 /M phase (24 ± 2%) than the uninfected ones (15 ± 2% and 13 ± 2% for S and G 2 /M phase, respectively). On the other hand, the number of cells in G 0 /G 1 phase was considerably lower in the hMPV-infected than in uninfected cultures (53 ± 3% and 72 ± 4%, respectively). At 28 dpi the A549 cells were coming out of cell cycle arrest in G 2 /M. Indeed, the cells accumulated in G 0 /G 1 , S and G 2 /M with an average of 60 ± 4%, 19 ± 4% and 21 ± 2%, respectively. At day 42 post-infection cells overcame the cell cycle block in G 2 /M and no longer accumulated in S and G 2 /M phase (14 ± 2% and 13 ± 3%, respectively), whereas the number of cells in G 0 /G 1 phase considerably increased (71 ± 5%), as compared with cells at day 14 post-infection (53 ± 3%).
Interestingly, A549 cells that had recovered from cell cycle arrest revealed a significant decrease in hMPV protein F expression, with as much as 59 ± 7% of cells apparently negative at 42 dpi (Fig. 6b) . In light of this evidence we generated clones from hMPV-infected cells at 42 dpi by seeding 0.5 cells in each well of a 96-well plate. The occurrence of clones was established by the evidence of a single colony per well. We obtained 34 clones and all of them showed detectable viral RNA in the supernatant, indicating that the heterogeneity of protein F expression, observed in the mixed culture, probably depends on low level hMPV replication per cell. Five clones were randomly selected for further characterization. In the presence of the same culture conditions, hMPV-infected clones grew more slowly than the uninfected A549 cells (median doubling time of clones 45 h, range 41-50 h; A549 doubling time 26 h). Moreover, clones maintained a protein F expression equal to the one observed in the bulk culture at 42 dpi.
Finally, we generated a clonal cell line (F12) continuously expressing hMPV, which has been maintained in culture for more than 1 year. The F12 supernatant was checked for the presence of infectious virions by assessing its ability to infect LLC-MK2 cells in comparison with the hMPV NL001 original strain. To this end, LLC-MK2 cells were infected with 10 6 copies/ml of NL001 or F12-derived strains and, after 48 h, cells were examined for protein F expression by flow cytometry. As shown in Fig. 7a , the percentage of infected cells and their fluorescence intensity were superimposable, suggesting that the virus released by persistently infected cells maintained the same virulence as the original strain. Supernatants collected from LLC-MK2 cells infected with original NL-001 or F12-derived strain were then checked for virus release over time (1, 2, 3, 5 and 7 dpi) by real-time PCR. Again, data obtained highlighted a comparable production of hMPV from both LLC-MK2 infections (Fig. 7b) . The infectious titer was confirmed by a limiting dilution assay. Overall, our data show that hMPV is able to persist for more than 42 days in A549 cells, which overcome the apoptotic process and acquire a reservoir cell phenotype with constant production of infectious virus.
B-cell lymphoma 2 expression accounts for inhibition of the apoptotic process in hMPV persistently infected A549 cells
The capability of hMPV to establish a persistent infection might be linked to the ability of cells, after the acute phase infection, to up-regulate Bcl-2, a key protein considered a focal point of apoptosis regulation in virus-infected cells (Galluzzi et al. 2008; Merry and Korsmeyer 1997) . Therefore, in order to understand the mechanism that allows hMPV to persist in A549 cells, we checked infected cells for the expression of the anti-apoptotic protein Bcl-2, which was previously found to be responsible for RSV persistence in a macrophage-derived cell line (NakamuraLopez et al. 2011) . To this aim western blot analysis was performed on hMPV-infected A549 cell lysates obtained at different times post-infection and on lysates of the F12 clone. Figure 8 shows that in F12 cells the presence of hMPV induced an increased expression of Bcl-2, while it remained unvaried during acute infection. The increased expression of Bcl2 in the F12 clone may explain, at least in part, why infected A549 cells do not undergo apoptosis after cell cycle arrest in G 2 /M phase but resume growth, although more slowly than uninfected cells.
DISCUSSION
In this study we show that hMPV is able to persistently infect human alveolar epithelial cells, which acquire a reservoir cell phenotype with constant production of infectious virus. In the acute phase of respiratory viral infection, many cells undergo apoptosis (Hermann, Zeiher and Dimmeler 1997; Megyeri et al. 1999) , contributing to the obstruction of the airways with consequent pathological manifestations. Then, some viruses are able to prolong their survival in infected cells and facilitate the establishment of persistence (Lamkanfi and Dixit 2010; Thomson 2001). The cytopathic effect induced in A549 epithelial cells during the first days of infection by hMPV suggests that the virus triggers apoptotic pathways. Indeed, apoptosis was confirmed by the presence of apoptotic nuclei, PARP-1 inactivation, and caspase-3 and -7 activation in the first 7 dpi. Moreover, hMPVinduced apoptosis was shown to depend on Wee1 phosphorylation. On the other hand, the reduction of caspases-3 and -7 activity, PARP-1 cleavage and Wee1 phosphorylation observed at 14 dpi, along with the observation that at that time hMPVinfected cells were found to be metabolically active, could represent the beginning of a coexistence between epithelial cells and hMPV, with a transition from the acute phase of infection to the persistent one. Indeed, prevention of apoptosis in virusinfected cells is likely to represent a critical step in establishing and maintaining viral persistence, since viruses benefit from the host cell enhanced survival (Young, Dawson and Eliopoulos 1997; Hardwick 1998; Barber 2001) . hMPV infection, as previously described for RSV (Gibbs et al. 2009 ), leads to an arrest in G 2 /M phase with a slowdown of cell replication and an increased Wee1 protein activity, as already shown for other viruses (Li et al. 2011) . Prolonged cell cycle arrest, observed in hMPV infection, likely triggers adverse effects on lung epithelium. Indeed, it is plausible that during viral infection a block of the cell cycle may impede lung repair inducing severe bronchiolitis (Gibbs et al. 2009) .
Viruses able to persist into the host have evolved mechanisms that interfere with the activity of caspases. These proteolytic enzymes are considered the key molecules of cell death response and their activity can be altered by modulation of Bcl-2 protein, a major regulator of cell survival. Here we show that in chronically infected hMPV cells the apoptotic program is subverted by an increased expression of the anti-apoptotic Bcl-2 protein, which other than preventing activation of caspases (Kluck et al. 1997; Adams and Cory 2001) , may lead to greater stability of the mitochondrial membrane by promoting mitochondrial respiration and sequestration of anti-apoptotic proteins (Nakamura-Lopez et al. 2011) . It is precisely this resistance of alveolar epithelial cells to apoptotic pathways through overexpression of Bcl-2 that more likely facilitates the establishment of persistent hMPV infection.
The hMPV genome does not contain structural proteins capable of conditioning target cell functions. For this reason, it is difficult to explain hMPV persistence due to the virus itself, which is programmed to replicate and kill cells during the acute phase of infection. The establishment of a persistence in human lung epithelial cells following an acute insult is likely to be attributable to a cell adaptation to the virus life cycle, by down-modulating the apoptotic pathway. However, recent data showed that the establishment of paramyxovirus persistence can be facilitated by defective viral genomes, generated during viral replication, which selectively protect cells from death and represent the primary triggers of antiviral immunity. In particular, cells respond to defective viral genomes inducing the expression of antiviral molecules that restrict virus production and on the other hand the defective genomes engage a pro-survival tumor necrosis factor receptor 2/tumor necrosis factor receptor-associated factor 1-dependent mechanism that promotes viral persistence. This study reveals the existence of an intricate mechanism in which virus and host establish a symbiotic interaction and also complex host-pathogen interactions that may, in part, explain the co-existence of viruses with their hosts (Xu et al. 2017) . Further studies are needed to understand the ability of hMPV to persist in human lung epithelial cells by producing defective viral genomes.
Overall, our results suggest that alveolar epithelium, probably together with other tissues (Schildgen et al. 2004) , might represent a potential viral reservoir of hMPV. Several lines of evidence suggest that hMPV infection may result in persistence, including detection of hMPV genomic RNA in the lung of hMPVinfected mice for more than 180 dpi (Alvarez et al. 2004 ) and in neuronal cell processes that innervate the lung (Liu et al. 2009 ). Viral persistence was found to occur in the presence of high titer neutralizing antibodies and effective cell mediated immunity (Alvarez et al. 2004) , thus suggesting that hMPV may circumvent the host immune response. Indeed, several studies have shown that hMPV infection inhibits innate immune responses and causes aberrant adaptive responses (Alvarez and Tripp 2005; Herd et al. 2006) . These findings suggest the presence of still unknown additional factors contributing to hMPV persistence in vivo. Further in-depth studies need to be undertaken to elucidate the mechanisms that hMPV utilizes to evade the host immune response.
In conclusion, our findings provide a better understanding of the mechanisms responsible for hMPV persistence in the human lung epithelial cells. Due to its ability to select cells for its chronic replication and to avoid clearance by the immune system, hMPV is likely to persist for a long time in lung after the acute phase of infection and cause long-term lung damage leading to chronic obstructive pulmonary disease and asthma. These commonalities provide a point of focus for researchers hoping to develop new intervention strategies in combating long-lasting hMPV infection and preventing hMPV-induced chronic lung diseases.
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